Skip to content

ICAAC: High mortality rate from symptomatic lactic acidosis in Thailand

ICAAC: Hardening of the arteries found in one in five patients in Swiss HIV cohort

WHO to monitor ARV side-effects worldwide

Switch to nevirapine safe for treatment-experienced patients with high CD4 cell counts

Over one year of 3TC use associated with increased risk of diabetes for HIV-positive women

Patients with undetectable viral load, but a CD4 cell count below 200 may be able to stop PCP prophylaxis

HIV/HCV coinfected patients who develop severe allergy to nevirapine have significantly increased risk of death

Increased fat consumption observed in people with HIV with high cholesterol

Frequency and seriousness of lactic acidosis mean that d4T should not be used in first-line therapy, say Ugandan researchers